Adalimumab: 40 mg/0.8 mL injection, 2 × 0.8 mL cartridges, 40 mg/0.8 mL injection, 2 × 0.8 mL syringes, 40 mg/0.8 mL injection, 6 × 0.8 mL cartridges, 40 mg/0.8 mL injection, 6 × 0.8 mL syringes, Humira®

Page last updated: 28 October 2016

• Public Summary Document (PSD) July 2016 PBAC Meeting - (PDF 259KB)
• Public Summary Document (PSD) July 2016 PBAC Meeting - (Word 86KB)